Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 25, 2013
A pharmacokinetics and safety comparison of a highly concentrated tobramycin solution with TOBIMatthias Griese, Claudia Eismann, Gerhard Börner, et al.
Lancet (London, England)|March 29, 2002
Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcomaPeter Würl, Matthias Kappler, Axel Meye, et al.
ERJ Open Research|March 18, 2026
Long-term impact of elexacaftor/tezacaftor/ivacaftor on small and large airways in people with cystic fibrosis aged ≥6 years: 24-month real-world evidence from the German Cystic Fibrosis RegistryStefanie Dillenhöfer, Katharina Schütz, Manuel Burkhart, et al.
Clinical Chemistry|February 28, 2002
Age-related reference values for serum selenium concentrations in infants and childrenAnia C Muntau, Monika Streiter, Matthias Kappler, et al.
The Journal of Allergy and Clinical Immunology|January 3, 2006
Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosisDominik Hartl, Matthias Griese, Matthias Kappler, et al.
BMC Bioinformatics|August 24, 2019
Prediction of regulatory targets of alternative isoforms of the epidermal growth factor receptor in a glioblastoma cell lineClaus Weinholdt, Henri Wichmann, Johanna Kotrba, et al.
Oncology Reports|September 18, 2004
Radiosensitization of a human soft tissue sarcoma cell line US8-93 (mt-p53) with the oxidizer sodium peroxodisulfateMatthias Bache, Jürgen Dunst, Frank Matschiner, et al.
BMC Cancer|April 5, 2012
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patientsAntje Hahnel, Henri Wichmann, Thomas Greither, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2014
Targeting of EGFR and HER2 with therapeutic antibodies and siRNA: a comparative study in glioblastoma cellsHenri Wichmann, Antje Güttler, Matthias Bache, et al.
International Journal of Oncology|September 18, 2004
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growthShuangli Ning, Susanne Fuessel, Matthias Kotzsch, et al.
Pageof 13